Logo image of TRKA

TROIKA MEDIA GROUP INC (TRKA) Stock Fundamental Analysis

NASDAQ:TRKA - Nasdaq - US89689F4046 - Common Stock - Currency: USD

0.133  -0.09 (-40.89%)

After market: 0.109 -0.02 (-18.05%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TRKA. TRKA was compared to 97 industry peers in the Media industry. Both the profitability and financial health of TRKA have multiple concerns. TRKA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

TRKA had negative earnings in the past year.
In the past year TRKA had a positive cash flow from operations.
In the past 5 years TRKA always reported negative net income.
In the past 5 years TRKA always reported negative operating cash flow.
TRKA Yearly Net Income VS EBIT VS OCF VS FCFTRKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

TRKA has a Return On Assets of -20.38%. This is amonst the worse of the industry: TRKA underperforms 83.67% of its industry peers.
TRKA has a worse Return On Equity (-214.39%) than 90.82% of its industry peers.
Industry RankSector Rank
ROA -20.38%
ROE -214.39%
ROIC N/A
ROA(3y)-32.79%
ROA(5y)-28.72%
ROE(3y)-221.13%
ROE(5y)-167.59%
ROIC(3y)N/A
ROIC(5y)N/A
TRKA Yearly ROA, ROE, ROICTRKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 200 -200 -400 -600

1.3 Margins

The Gross Margin of TRKA (13.15%) is worse than 83.67% of its industry peers.
TRKA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TRKA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.4%
GM growth 5Y-6.12%
TRKA Yearly Profit, Operating, Gross MarginsTRKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

0

2. Health

2.1 Basic Checks

TRKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TRKA has been increased compared to 1 year ago.
The debt/assets ratio for TRKA is higher compared to a year ago.
TRKA Yearly Shares OutstandingTRKA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
TRKA Yearly Total Debt VS Total AssetsTRKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

TRKA has an Altman-Z score of -0.69. This is a bad value and indicates that TRKA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.69, TRKA is not doing good in the industry: 81.63% of the companies in the same industry are doing better.
The Debt to FCF ratio of TRKA is 43.51, which is on the high side as it means it would take TRKA, 43.51 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 43.51, TRKA is doing worse than 60.20% of the companies in the same industry.
A Debt/Equity ratio of 4.61 is on the high side and indicates that TRKA has dependencies on debt financing.
TRKA has a Debt to Equity ratio of 4.61. This is amonst the worse of the industry: TRKA underperforms 89.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.61
Debt/FCF 43.51
Altman-Z -0.69
ROIC/WACCN/A
WACC4.35%
TRKA Yearly LT Debt VS Equity VS FCFTRKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.59 indicates that TRKA may have some problems paying its short term obligations.
The Current ratio of TRKA (0.59) is worse than 90.82% of its industry peers.
TRKA has a Quick Ratio of 0.59. This is a bad value and indicates that TRKA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of TRKA (0.59) is worse than 90.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
TRKA Yearly Current Assets VS Current LiabilitesTRKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.86% over the past year.
Looking at the last year, TRKA shows a very strong growth in Revenue. The Revenue has grown by 162.54%.
TRKA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 186.79% yearly.
EPS 1Y (TTM)79.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.51%
Revenue 1Y (TTM)162.54%
Revenue growth 3Y41.83%
Revenue growth 5Y186.79%
Sales Q2Q%-31.26%

3.2 Future

Based on estimates for the next years, TRKA will show a very negative growth in Earnings Per Share. The EPS will decrease by -37.86% on average per year.
TRKA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.92% yearly.
EPS Next Y-96%
EPS Next 2Y-51.01%
EPS Next 3Y-37.86%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y20%
Revenue Next 3Y12.92%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TRKA Yearly Revenue VS EstimatesTRKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
TRKA Yearly EPS VS EstimatesTRKA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

4

4. Valuation

4.1 Price/Earnings Ratio

TRKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 2.17, the valuation of TRKA can be described as very cheap.
Based on the Price/Forward Earnings ratio, TRKA is valued cheaply inside the industry as 98.98% of the companies are valued more expensively.
TRKA is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.37, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2.17
TRKA Price Earnings VS Forward Price EarningsTRKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TRKA is valued cheaply inside the industry as 97.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.47
EV/EBITDA N/A
TRKA Per share dataTRKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

TRKA's earnings are expected to decrease with -37.86% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.01%
EPS Next 3Y-37.86%

0

5. Dividend

5.1 Amount

TRKA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TROIKA MEDIA GROUP INC

NASDAQ:TRKA (12/15/2023, 8:20:01 PM)

After market: 0.109 -0.02 (-18.05%)

0.133

-0.09 (-40.89%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change0%
Ins Owners191.24%
Ins Owner Change0%
Market Cap2.22M
Analysts82.86
Price Target38.25 (28659.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.17
P/S 0.01
P/FCF 1.47
P/OCF 1.39
P/B 0.16
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.66
EYN/A
EPS(NY)0.06
Fwd EY46.02%
FCF(TTM)0.09
FCFY68.07%
OCF(TTM)0.1
OCFY72.12%
SpS18.32
BVpS0.83
TBVpS-5.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.38%
ROE -214.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.15%
FCFM 0.49%
ROA(3y)-32.79%
ROA(5y)-28.72%
ROE(3y)-221.13%
ROE(5y)-167.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.4%
GM growth 5Y-6.12%
F-Score4
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity 4.61
Debt/FCF 43.51
Debt/EBITDA N/A
Cap/Depr 1.65%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z -0.69
F-Score4
WACC4.35%
ROIC/WACCN/A
Cap/Depr(3y)4.81%
Cap/Depr(5y)4.93%
Cap/Sales(3y)0.51%
Cap/Sales(5y)0.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.51%
EPS Next Y-96%
EPS Next 2Y-51.01%
EPS Next 3Y-37.86%
EPS Next 5YN/A
Revenue 1Y (TTM)162.54%
Revenue growth 3Y41.83%
Revenue growth 5Y186.79%
Sales Q2Q%-31.26%
Revenue Next Year0%
Revenue Next 2Y20%
Revenue Next 3Y12.92%
Revenue Next 5YN/A
EBIT growth 1Y69.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.78%
EBIT Next 3Y31.1%
EBIT Next 5YN/A
FCF growth 1Y135.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y138.19%
OCF growth 3YN/A
OCF growth 5YN/A